Radioimmunoassay market size is projected to a market value of USD 470.01 Million by 2023, globally.
The major factors affecting the Global Radioimmunoassay Market include the high investment, the increasing emphasis on R&D in the sector, technological advancements, their increased usage in pharmaceutical industries, research, rising need for quality and
(EMAILWIRE.COM, August 28, 2018 ) Market Overview:
In the year 2018 Global Radioimmunoassay Market was valued at USD 395.43 Million. By the year 2023, it is predicted to reach USD 470.01 Million with pace of 3.52% CAGR.
Radioimmunoassay (RIA) is mainly used in-vitro assay techniques to measure the concentration of antigens in blood. It is a highly sensitive technique where it can measure even the smallest amount of hormone or drug level with the help of antibodies. . Radioimmunoassay plays a significant role in the medical field due to precision, accuracy, specificity of results, and sensitivity. RIA technique is used in various applications like early detection and diagnosis of cancer, neurodegenerative disorders and other chronic diseases. This technique is also used in pharmaceutical industry for discovering of new drugs.
Request Report Sample: https://www.marketdataforecast.com/market-reports/radioimmunoassay-market-3701/request-sample
Factors affecting market growth:
Rising prevalence of cancer and other chronic diseases globally. (+)
Increasing investment in R&D activities. (+)
Advancement of technologies. (+)
Increasing use in pharmaceutical and other industries. (+)
Growing aging population across the globe. (+)
Increasing demand for automation in healthcare services. (+)
High cost of equipment. (-)
Stringent regulatory policies. (-)
Lack of skilled professionals. (-)
Get your customized report: https://www.marketdataforecast.com/market-reports/radioimmunoassay-market-3701/customize-report
Market Segmentation
The Global Radioimmunoassay Market is segmented on the basis of
Type
Reagents and Kits
Analyzers
End User
Hospital
Pharmaceutical Industry and CRO
Clinical Diagnostic Laboratories
Application
Research
Clinical Diagnostics
Based on type market, Reagents and Kits segment holds the largest market share in the Global Radioimmunoassay Market. Besides, clinical diagnosis segment is rapidly growing due to rising prevalence of chronic diseases in the Radioimmunoassay Market. On the basis of End user market, Clinical Diagnostic Laboratories are anticipated to propel high growth rate in the Global Radioimmunoassay Market during the forecast period.
Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/radioimmunoassay-market-3701/
Key players:
Major companies for Global Radioimmunoassay Market are MP Biomedicals, LLC, Cisbio, Euro Diagnostica AB, DiaSorin S.p.A.., EMD Millipore, Izotop, Berthold Technologies GmbH & Co. KG and Stratec Biomedical AG, DIAsource ImmunoAssays SA, Beckman Coulter, Inc, IBL International, PerkinElmer, Inc., and DRG International, Inc.
In the year 2018 Global Radioimmunoassay Market was valued at USD 395.43 Million. By the year 2023, it is predicted to reach USD 470.01 Million with pace of 3.52% CAGR.
Radioimmunoassay (RIA) is mainly used in-vitro assay techniques to measure the concentration of antigens in blood. It is a highly sensitive technique where it can measure even the smallest amount of hormone or drug level with the help of antibodies. . Radioimmunoassay plays a significant role in the medical field due to precision, accuracy, specificity of results, and sensitivity. RIA technique is used in various applications like early detection and diagnosis of cancer, neurodegenerative disorders and other chronic diseases. This technique is also used in pharmaceutical industry for discovering of new drugs.
Request Report Sample: https://www.marketdataforecast.com/market-reports/radioimmunoassay-market-3701/request-sample
Factors affecting market growth:
Rising prevalence of cancer and other chronic diseases globally. (+)
Increasing investment in R&D activities. (+)
Advancement of technologies. (+)
Increasing use in pharmaceutical and other industries. (+)
Growing aging population across the globe. (+)
Increasing demand for automation in healthcare services. (+)
High cost of equipment. (-)
Stringent regulatory policies. (-)
Lack of skilled professionals. (-)
Get your customized report: https://www.marketdataforecast.com/market-reports/radioimmunoassay-market-3701/customize-report
Market Segmentation
The Global Radioimmunoassay Market is segmented on the basis of
Type
Reagents and Kits
Analyzers
End User
Hospital
Pharmaceutical Industry and CRO
Clinical Diagnostic Laboratories
Application
Research
Clinical Diagnostics
Based on type market, Reagents and Kits segment holds the largest market share in the Global Radioimmunoassay Market. Besides, clinical diagnosis segment is rapidly growing due to rising prevalence of chronic diseases in the Radioimmunoassay Market. On the basis of End user market, Clinical Diagnostic Laboratories are anticipated to propel high growth rate in the Global Radioimmunoassay Market during the forecast period.
Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/radioimmunoassay-market-3701/
Key players:
Major companies for Global Radioimmunoassay Market are MP Biomedicals, LLC, Cisbio, Euro Diagnostica AB, DiaSorin S.p.A.., EMD Millipore, Izotop, Berthold Technologies GmbH & Co. KG and Stratec Biomedical AG, DIAsource ImmunoAssays SA, Beckman Coulter, Inc, IBL International, PerkinElmer, Inc., and DRG International, Inc.
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results